Tri-Sprintec

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 20, 2023
Approval ID: 843cbef6-cbfb-4a44-bb80-22930753e4c0
Products: 1 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TRI-SPRINTEC safely and effectively. See full prescribing information for TRI-SPRINTEC. TRI-SPRINTEC (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989

Quick Stats

Total Products1

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.